文献速递颈动脉与弓上血管

颈动脉内膜切除术后放置引流无获益:VQI注册分析

Drain placement confers no benefit after carotid endarterectomy in the Vascular Quality Initiative.
PubMed 文献 · J Vasc Surg · 2020-02-13

基于VQI注册2011-2015年47752例颈动脉内膜切除术患者,比较放置引流(19425例)与未放置引流(28327例)的结局。引流未减少因出血重返手术室,也未降低30天卒中或死亡,但住院时间延长。

要点

  • 颈动脉内膜切除术后放置引流不减少因出血重返手术室。
  • 引流不降低30天卒中、死亡或联合卒中/死亡风险。
  • 引流与住院时间延长相关,临床不应常规放置。

核心结论

  • 颈动脉内膜切除术后放置引流不减少因出血重返手术室,也不减少围术期卒中或死亡。
  • 放置引流与住院时间延长相关。

研究设计与样本

  • 基于Vascular Quality Initiative注册的回顾性队列研究,纳入2011至2015年47752例颈动脉内膜切除术患者。
  • 放置引流组19425例,未放置引流组28327例,比较人口学、术前和术中因素及术后结局。
  • 采用混合效应逻辑回归模型控制中心内相关性,并按中心引流使用率高中低分组进行亚组分析。

主要发现

  • 放置引流组更常术前使用P2Y12拮抗剂(P < .001)、有颈动脉内膜切除术或颈动脉支架史(P < .001)、使用右旋糖酐(P < .001)、合并其他手术或冠脉搭桥(P < .001),较少使用鱼精蛋白(P < .001)。
  • 放置引流未预防因出血重返手术室(P < .22)。
  • 在放置引流患者中,重返手术室探查颈动脉(P < .001)、术前使用P2Y12拮抗剂(P < .001)和未使用鱼精蛋白(P < .001)是因出血重返手术室的预测因素。
  • 因出血重返手术室的患者中,引流未影响30天卒中(P = .82)、30天死亡(P = .43)或30天联合卒中/死亡(P = .42)。
  • 引流未影响术后伤口感染(P < .3),但引流组住院时间延长(P < .001)。

临床怎么用

  • 颈动脉内膜切除术后不应常规放置引流以预防出血并发症。
  • 应关注术前P2Y12拮抗剂使用、未使用鱼精蛋白和术中重返探查颈动脉等出血重返手术室预测因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Whereas bleeding complications requiring a return to the operating room (OR) after carotid endarterectomy (CEA) are infrequent (1%), they are associated with an increased 30-day combined postoperative stroke or death rate. Drain placement after CEA varies among vascular surgeons, and there are limited data to support the practice. The goal of this study was to evaluate factors leading to drain placement and the effect of drains on postoperative outcomes including return to OR for bleeding, stroke, and death. METHODS: There were 47,752 patients identified undergoing CEA using the Vascular Quality Initiative registry from 2011 to 2015. Demographic, preoperative, and intraoperative factors between patients who underwent CEA with (n = 19,425) and without (n = 28,327) drain placement were compared. End points included return to the OR for bleeding, stroke, death, postoperative wound infection, and hospital length of stay. We then compared postoperative outcomes between groups using mixed effect logistic regression models to control for correlation within center. Similar methods were used to show relationship between return to OR for bleeding and other variables. Subgroup analysis of patients with drain placement was compared among centers with high (>66.7% of cases), medium (33.3%-66.7%), and low (<33.3%) use. RESULTS: Patients with drain placement were more likely to be taking a preoperative P2Y12 antagonist (P < .001), to have prior CEA or carotid artery stenting (P < .001), to use dextran (P < .001), and to have a concomitant procedure or coronary artery bypass graft (P < .001) and less likely to use protamine (P < .001) compared with those without drain placement. Drain placement did not prevent return to the OR for bleeding (P < .22). Re-exploration of the carotid artery after closure in the OR (P < .001), preoperative P2Y12 antagonist use (P < .001), and no protamine use (P < .001) were predictors for return to the OR for bleeding among those with drain placement. Of patients requiring return to the OR for bleeding, drain placement did not influence 30-day stroke (P = .82), 30-day mortality (P = .43), or 30-day combined stroke/mortality (P = .42) compared with those without drain placement. Drain placement did not influence postoperative wound infection (P < .3). Hospital length of stay was increased in patients with drain placement (P < .001). Return to the OR for bleeding (P = .24), wound infection (P = .16), and length of stay (P = .94) did not differ between the groups of high, medium, and low drain use. CONCLUSIONS: Drain placement after CEA does not reduce return to the OR for bleeding, nor does it reduce perioperative stroke or death. Drain placement is associated with increased length of stay.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Smolock CJ, Morrow KL, Kang J, et al. Drain placement confers no benefit after carotid endarterectomy in the Vascular Quality Initiative. J Vasc Surg. 2020. PMID: 32061481. doi:10.1016/j.jvs.2019.09.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。